Grants Search Results
Need help? Call us at (888) 899-2253
Interested in applying for a St. Baldrick's Foundation grant? Learn more about the grant application process.
Showing 401-420 of 645 results
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Ann Arbor, MI
Institution: C.S. Mott Children’s Hospital
affiliated with University of Michigan
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Aurora, CO
Institution: Children's Hospital Colorado
affiliated with University of Colorado
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Seattle, WA
Institution: Seattle Children's Hospital
affiliated with Fred Hutchinson Cancer Research Center, University of Washington
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Boston, MA
Institution: Boston Children's Hospital
affiliated with Dana-Farber Cancer Institute, Harvard Medical School
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Chicago, IL
Institution: The University of Chicago
affiliated with Comer Children's Hospital
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Atlanta, GA
Institution: Children's Healthcare of Atlanta
affiliated with Emory University, Children's Healthcare of Atlanta at Egleston, Aflac Cancer Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Toronto, ON
Institution: Hospital for Sick Children
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
Ft. Worth, TX
Institution: Cook Children's Medical Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014
through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location:
New York, NY
Institution: Memorial Sloan Kettering Cancer Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.
North American Consortium for Histiocytosis (NACHO) Member
Funded: 07-01-2014
through 06-30-2019
Funding Type: Consortium Research Grant
Institution Location:
Baltimore, MD
Institution: Johns Hopkins University School of Medicine
affiliated with Johns Hopkins Children's Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.
North American Consortium for Histiocytosis (NACHO) Member
Funded: 07-01-2014
through 06-30-2019
Funding Type: Consortium Research Grant
Institution Location:
Louisville, KY
Institution: Norton Children's Hospital
affiliated with University of Louisville
This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.
North American Consortium for Histiocytosis (NACHO) Member
Funded: 07-01-2014
through 06-30-2019
Funding Type: Consortium Research Grant
Institution Location:
Charlotte, NC
Institution: Levine Children's Hospital at Carolinas Medical Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.
North American Consortium for Histiocytosis (NACHO) Member
Funded: 07-01-2014
through 06-30-2019
Funding Type: Consortium Research Grant
Institution Location:
Macon, GA
Institution: Beverly Knight Olson Children's Hospital Navicent Health
This institution is a member of a research consortium which is being funded by St. Baldrick's: North American Consortium for Histiocytosis (NACHO). For a description of this project, see the consortium grant made to the lead institution: St. Jude Children's Research Hospital, Memphis, TN.
Pathway Directed Treatment for Refractory AML Consortium
Funded: 07-01-2013
through 03-31-2020
Funding Type: Consortium Research Grant
Institution Location:
Seattle, WA
Institution: Fred Hutchinson Cancer Research Center
affiliated with University of Washington, Seattle Children's Hospital
Despite the toxic effects of current treatment for children and young adults with AML, overall survival remains poor because of recurrent leukemia. If their AML does not respond to chemotherapy after relapse, chances for survival are low. This team has identified important changes in AML that can be exploited to develop more effective and less toxic treatments using new types of drugs. The consortium focuses on showing that these pathways are needed for leukemia survival, and developing pathway-directed clinical trials to improve outcomes for this group of patients with no other treatment options. Awarded to Phoenix Children's Hospital and transferred to Fred Hutchinson Cancer Research Center. Funds administered by Fred Hutchinson Cancer Research Center.
Pathway Directed Treatment for Refractory AML Consortium Member
Funded: 07-01-2013
through 03-31-2020
Funding Type: Consortium Research Grant
Institution Location:
Portland, OR
Institution: Oregon Health and Science University
affiliated with Doernbecher Children's Hospital
This institution is a member of a research consortium which is being funded by St. Baldrick's: Pathway Directed Treatment for Refractory AML Consortium. For a description of this project, see the consortium grant made to the lead institution: Fred Hutchinson Cancer Research Center, Seattle, WA.
Pathway Directed Treatment for Refractory AML Consortium Member
Funded: 07-01-2013
through 03-31-2020
Funding Type: Consortium Research Grant
Institution Location:
Phoenix, AZ
Institution: Phoenix Children's Hospital
This institution is a member of a research consortium which is being funded by St. Baldrick's: Pathway Directed Treatment for Refractory AML Consortium. For a description of this project, see the consortium grant made to the lead institution: Fred Hutchinson Cancer Research Center, Seattle, WA.
Pathway Directed Treatment for Refractory AML Consortium Member
Funded: 07-01-2013
through 03-31-2020
Funding Type: Consortium Research Grant
Institution Location:
Los Angeles, CA
Institution: University of Southern California
This institution is a member of a research consortium which is being funded by St. Baldrick's: Pathway Directed Treatment for Refractory AML Consortium. For a description of this project, see the consortium grant made to the lead institution: Fred Hutchinson Cancer Research Center, Seattle, WA.
Pathway Directed Treatment for Refractory AML Consortium Member
Funded: 07-01-2013
through 03-31-2020
Funding Type: Consortium Research Grant
Institution Location:
Scottsdale, AZ
Institution: Translational Genomics Research Institute (TGen)
This institution is a member of a research consortium which is being funded by St. Baldrick's: Pathway Directed Treatment for Refractory AML Consortium. For a description of this project, see the consortium grant made to the lead institution: Fred Hutchinson Cancer Research Center, Seattle, WA.
Pathway Directed Treatment for Refractory AML Consortium Member
Funded: 07-01-2013
through 03-31-2020
Funding Type: Consortium Research Grant
Institution Location:
Palo Alto, CA
Institution: Stanford University
affiliated with Lucile Packard Children’s Hospital
This institution is a member of a research consortium which is being funded by St. Baldrick's: Pathway Directed Treatment for Refractory AML Consortium. For a description of this project, see the consortium grant made to the lead institution: Fred Hutchinson Cancer Research Center, Seattle, WA.
PBMTC Late Effects Consortium
Funded: 07-01-2013
through 09-30-2020
Funding Type: Consortium Research Grant
Institution Location:
Boston, MA
Institution: Dana-Farber Cancer Institute
affiliated with Boston Children's Hospital, Harvard Medical School
Children treated with bone marrow transplant (HSCT) for high-risk leukemia are at risk for late effects of treatment that can significantly impact their quality of life and survival. There are very few multi-center studies of these toxicities. This consortium studies organ-specific late effects, tests a screening regimen, and investigates biomarkers of disease in survivors of pediatric HSCT. The goals of this project are to better understand, prevent, and treat late effects of childhood transplant resulting in improved long-term survival. Funds administered by Dana-Farber Cancer Institute.